Sort by
Refine Your Search
-
of theranostic radioligands targeting tumor-associated proteases. Project overview: The Radiopharmacy group has extensive expertise in the development of radiolabeled ligands for proteases implicated in human
-
research activities within the Radiopharmacy (CREANT) department and the Molecular Imaging Center Antwerp (MICA), focusing on the preclinical evaluation of theranostic radioligands targeting tumor
-
economic sociology, the sociology of imagined futures or related fields of research is considered an asset. You have a proven track record of publishing in international, peer-reviewed journals. You are
-
considered an asset. You have a proven track record of publishing in international, peer-reviewed journals. You are reliable, capable of working independently, and demonstrate initiative. You possess strong